Search | WHO COVID-19 Research Database

Reply to 'Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study' by Bawane J et al.

Potestio, L; Genco, L; Villani, A; Marasca, C; Fabbrocini, G; Fornaro, L; Ruggiero, A; Martora, F.

J Eur Acad Dermatol Venereol ; 36(11): e863-e864, 2022 11.

Article in English | MEDLINE | ID: covidwho-1895995

Subject(s)

COVID-19 Vaccines , COVID-19 , Drug-Related Side Effects and Adverse Reactions , COVID-19/prevention & control , COVID-19 Vaccines/adverse effects , Humans , India/epidemiology , Surveys and Questionnaires

Reply to 'Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2' by Solimani et al.

Martora, F; Fabbrocini, G; Nappa, P; Megna, M.

J Eur Acad Dermatol Venereol ; 36(10): e750-e751, 2022 10.

Article in English | MEDLINE | ID: covidwho-1883213

Subject(s)

COVID-19 Vaccines , COVID-19 , Pemphigus , Antibodies, Viral , BNT162 Vaccine , COVID-19/prevention & control , COVID-19 Vaccines/adverse effects , Humans , Pemphigus/etiology , SARS-CoV-2 , Vaccination

Herpes zoster after ChAdOx1 nCoV-19 vaccine: a case series.

Vastarella, M; Picone, V; Martora, F; Fabbrocini, G.

J Eur Acad Dermatol Venereol ; 35(12): e845-e846, 2021 Dec.

Article in English | MEDLINE | ID: covidwho-1345982

Subject(s)

COVID-19 , Herpes Zoster Vaccine , Herpes Zoster , Vaccines , COVID-19 Vaccines , ChAdOx1 nCoV-19 , Herpes Zoster Vaccine/adverse effects , Humans , SARS-CoV-2

Subject(s)

Subject(s)

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL